Clinical Trials Logo

Advanced Malignant Neoplasm clinical trials

View clinical trials related to Advanced Malignant Neoplasm.

Filter by:
  • Active, not recruiting  
  • Page 1 ·  Next »

NCT ID: NCT04503265 Active, not recruiting - Breast Cancer Clinical Trials

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Start date: August 12, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

ATLAS-101 is a Phase I/II clinical trial of AMXI-5001 in adult participants with advanced malignancies who have previously failed other therapies. The study has two phases. The purpose of Phase I (Dose Escalation) is to confirm the appropriate treatment dose and Phase II (Dose Expansion) is to characterize the safety and efficacy of AMXI-5001.

NCT ID: NCT04053517 Active, not recruiting - Clinical trials for Advanced Malignant Neoplasm

Financial Distress in Advanced Cancer Patients

Start date: July 2, 2019
Phase:
Study type: Observational

This trial studies the severity of financial distress in advanced cancer patients. The cost of cancer care can often be very expensive. Financial distress from the burdens of high costs and debt may interfere with a patient's physical symptoms and quality of life.

NCT ID: NCT03856060 Active, not recruiting - Malignant Neoplasm Clinical Trials

Videos and Questionnaires in Assessing Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits

Start date: March 30, 2019
Phase: N/A
Study type: Interventional

This trial assesses patient perception of physician's compassion, communication skills, and professionalism during clinic visits through the use of videos and questionnaires.

NCT ID: NCT03707574 Active, not recruiting - Clinical trials for Anatomic Stage III Breast Cancer AJCC v8

Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study

Start date: April 9, 2019
Phase:
Study type: Observational

This trial studies the genetic analysis of blood and tissue samples from patients with cancer that has spread to other anatomic sites (advanced) or is no longer responding to treatment. Studying these samples in the laboratory may help doctors to learn how genes affect cancer and how they affect a person's response to treatment.

NCT ID: NCT03671226 Active, not recruiting - Caregiver Clinical Trials

Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center

Start date: September 28, 2018
Phase: N/A
Study type: Interventional

This trial studies the preference of room setting and waiting time in patients with cancer that has spread to nearby tissue or lymph nodes or other places in the body and their caregivers who are seen in the outpatient supportive/palliative care center. Room setting preferences of patients and caregivers may help to understand their opinion regarding direct rooming system in the outpatient supportive/palliative care center.

NCT ID: NCT03525873 Active, not recruiting - Clinical trials for Advanced Malignant Neoplasm

Methylphenidate and Physical Activity to Reduce Cancer Related Fatigue Due to Anti PD1 Immunotherapy

Start date: August 2, 2018
Phase: Phase 3
Study type: Interventional

This phase III trial studies how well methylphenidate and physical activity works in reducing cancer-related fatigue in patients who are receiving anti-PD1 immunotherapy for cancer that has spread to other places in the body. Central nervous systems stimulants, such as methylphenidate, may help to improve cognitive function. Physical activity uses techniques, such as aerobic and resistance exercises, which may help to improve quality of life. Giving methylphenidate and physical activity may help in reducing cancer-related fatigue in patients with metastatic cancer who receive anti-PD1 immunotherapy.

NCT ID: NCT03287492 Active, not recruiting - Caregiver Clinical Trials

RCT of QPS vs General Information Sheet

Start date: September 25, 2017
Phase: N/A
Study type: Interventional

This trial studies how well information materials work in helping communication between physicians and participants with cancer that has spread to other places in the body and their caregivers. Approaches that encourage participants to actively participate and ask appropriate questions during their visit may be important to enhance their understanding of their illness and empower them to make important decisions regarding their medical care.

NCT ID: NCT03122886 Active, not recruiting - Clinical trials for Advanced Malignant Neoplasm

Fat Emulsion in Preventing Hypersensitivity Reactions in Patients With Cancer Receiving Carboplatin or Oxaliplatin

Start date: July 14, 2017
Phase: N/A
Study type: Interventional

This randomized pilot trial studies how well fat emulsion works in preventing hypersensitivity reactions in patients with cancer receiving carboplatin or oxaliplatin. Giving lipids before chemotherapy may prevent some drug reactions from carboplatin or oxaliplatin.

NCT ID: NCT03069469 Active, not recruiting - Clinical trials for Advanced Malignant Neoplasm

Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor

Start date: February 16, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

This is a multicenter, open-label Phase 1/2 study of vimseltinib in patients with malignant solid tumors and tenosynovial giant cell tumor (TGCT). There will be 2 distinct parts in this study: Dose Escalation (Phase 1) and Expansion (Phase 2). Phase 1 will enroll both malignant solid tumor and TGCT patients. Phase 2 will comprise two cohorts (Cohort A and Cohort B) and will only enroll TGCT patients.

NCT ID: NCT03021486 Active, not recruiting - Delirium Clinical Trials

Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer

Start date: June 5, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

This randomized phase II/III trial studies how well haloperidol with or without chlorpromazine works in treating delirium in patients with cancer that has spread to other parts of the body or has come back. Haloperidol and chlorpromazine may control the symptoms of delirium (loss of contact with reality) in patients with cancer.